Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog

被引:261
作者
Xu, M [1 ]
Molento, M [1 ]
Blackhall, W [1 ]
Ribeiro, P [1 ]
Beech, R [1 ]
Prichard, R [1 ]
机构
[1] McGill Univ, Inst Parasitol, St Anne De Bellevue, PQ H9X 3V9, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Haemonchus contortus; P-glycoprotein; drug resistance; ivermectin;
D O I
10.1016/S0166-6851(97)00215-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resistance to ivermectin and related drugs is an increasing problem for parasite control. The mechanism of ivermectin resistance in nematode parasites is currently unknown. Some P-glycoproteins and multidrug resistance proteins have been found to act as membrane transporters which pump drugs from the cell. A disruption of the mdr1a gene, which encodes a P-glycoprotein in mice, results in hypersensitivity to ivermectin. Genes encoding members of the P-glycoprotein family are known to exist in nematodes but the involvement of P-glycoprotein in nematode ivermectin-resistance has not been described. Our data suggest that a P-glycoprotein may play a role in ivermectin resistance in the sheep nematode parasite Haemonchus contortus. A full length P-glycoprotein cDNA from H. contortus has been cloned and sequenced. Analysis of the sequence showed 61-65% homology to other P-glycoprotein/multidrug resistant protein sequences, such as mice, human and Caenorhabditis elegans. Expression of P-glycoprotein mRNA was higher in ivermectin-selected than unselected strains of H. contortus. An alteration in the restriction pattern was also found for the genomic locus of P-glycoprotein derived from ivermectin-selected strains of H. contortus compared with unselected strains. P-glycoprotein gene structure and/or its transcription are altered in ivermectin-selected H. contortus. The multidrug resistance reversing agent, verapamil, increased the efficacy of ivermectin and moxidectin against a moxidectin-selected strain of this nematode in jirds (Meriones unguiculatus). These data indicate that a P-glycoprotein may be involved in resistance to ivermectin and other macrocyclic lactones in H. contortus. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:327 / 335
页数:9
相关论文
共 36 条
[1]   THE MECHANISM OF ACTION OF AVERMECTINS IN CAENORHABDITIS-ELEGANS - CORRELATION BETWEEN ACTIVATION OF GLUTAMATE-SENSITIVE CHLORIDE CURRENT, MEMBRANE-BINDING, AND BIOLOGICAL-ACTIVITY [J].
ARENA, JP ;
LIU, KK ;
PARESS, PS ;
FRAZIER, EG ;
CULLY, DF ;
MROZIK, H ;
SCHAEFFER, JM .
JOURNAL OF PARASITOLOGY, 1995, 81 (02) :286-294
[2]  
AUSUBEL F, 1987, CURR PROTOC MOL BIOL, V1, P491
[3]  
BLACKHALL WJ, 1997, UNPUB SELECTION P GL
[4]   A P-GLYCOPROTEIN PROTECTS CAENORHABDITIS-ELEGANS AGAINST NATURAL TOXINS [J].
BROEKS, A ;
JANSSEN, HWRM ;
CALAFAT, J ;
PLASTERK, RHA .
EMBO JOURNAL, 1995, 14 (09) :1858-1866
[5]   Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans [J].
Broeks, A ;
Gerrard, B ;
Allikmets, R ;
Dean, M ;
Plasterk, RHA .
EMBO JOURNAL, 1996, 15 (22) :6132-6143
[6]   INTERNAL DUPLICATION AND HOMOLOGY WITH BACTERIAL TRANSPORT PROTEINS IN THE MDR1 (P-GLYCOPROTEIN) GENE FROM MULTIDRUG-RESISTANT HUMAN-CELLS [J].
CHEN, CJ ;
CHIN, JE ;
UEDA, K ;
CLARK, DP ;
PASTAN, I ;
GOTTESMAN, MM ;
RONINSON, IB .
CELL, 1986, 47 (03) :381-389
[7]   DEMONSTRATION OF CORESISTANCE OF HAEMONCHUS-CONTORTUS TO IVERMECTIN AND MOXIDECTIN [J].
CONDER, GA ;
THOMPSON, DP ;
JOHNSON, SS .
VETERINARY RECORD, 1993, 132 (26) :651-652
[8]   A NOVEL ANTHELMINTIC MODEL UTILIZING JIRDS, MERIONES-UNGUICULATUS, INFECTED WITH HAEMONCHUS-CONTORTUS [J].
CONDER, GA ;
JEN, LW ;
MARBURY, KS ;
JOHNSON, SS ;
GUIMOND, PM ;
THOMAS, EM ;
LEE, BL .
JOURNAL OF PARASITOLOGY, 1990, 76 (02) :168-170
[9]   CLONING OF AN AVERMECTIN-SENSITIVE GLUTAMATE-GATED CHLORIDE CHANNEL FROM CAENORHABDITIS-ELEGANS [J].
CULLY, DF ;
VASSILATIS, DK ;
LIU, KK ;
PARESS, PS ;
VANDERPLOEG, LHT ;
SCHAEFFER, JM ;
ARENA, JP .
NATURE, 1994, 371 (6499) :707-711
[10]   The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor [J].
Didier, A ;
Loor, F .
ANTI-CANCER DRUGS, 1996, 7 (07) :745-751